Personalized Cell Therapy Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Personalized cell therapy involves use of customized treatment for various diseases such as cancer and autoimmune diseases by injecting living cells into a patient’s body. Cell therapy is used for various applications such as platelet transfusions, bone marrow transplantation, whole blood transfusions, packed red cell transfusions, and organ transplantation. It is used to treat neurological diseases such as Parkinson’s disease and amyotrophic lateral sclerosis, spinal cord injuries, diabetes, and cancer. Various types of cells such as mature and immature solid tissue cells, adult stem cells, blood and bone marrow cells, and embryonic stem cells are used for personalized cell therapy. In recent years, cell therapy has received extensive acceptance among surgeons and patients due to its ability to treat various diseases. Several decades of R&D has allowed researchers to develop solutions that have otherwise eluded conventional therapeutics. This creates a highly conducive environment for growth of the global personalized cell therapy market.

According to Centre for Disease Control (CDC), globally, around 14.1 million people were diagnosed with cancer in 2012, leading to 8.2 million fatalities. It is projected that around 19.3 million new cases will diagnosed with cancer by 2025. Also, the prevalence of diabetes is increasing globally. According to International Diabetes Federation (IDF), over 415 million people are suffering from diabetes and this number is expected to reach 642 million by 2040. Increasing prevalence of chronic diseases is a major factor expected to fuel the growth of the global personalized cell therapy market.

Personalized Cell Therapy Market Taxonomy:

On the basis of therapeutic area, the global market is classified into:

  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory Diseases
  • Diabetes
  • Cancer
  • Cancer Stem Cells Therapy

Increasing government initiatives and funding for cancer and stem cell research is another major driver that propels market growth. For instance, in 2015, the National Institutes of Health invested around US$ 1,429 million in stem cell research. Stem cell therapy is one of the most promising treatment options for patients suffering from cancer. Thus, increasing funding by government is expected to drive adoption of personalized cell therapy products and services.

Increasing R & D activities in personalized cell therapy sector

Stem cells research offers great potential for better understanding of human development. However, the ethical and religious constraints for the use of embryonic stem cells, including human embryonic stem cell (hESC) for research, diagnosis, and treatment, could hinder growth of the personalized cell therapy market. The use of embryonic stem cells involves destruction of embryos, which is an unethical process according to certain factions of the society. In major developed countries such as Italy, Austria, Ireland, Germany, and Portugal, embryonic stem cell research is prohibited. Thus, the growth of the market could be hindered by stringent regulations for the stem cell research and its application in disease treatment.

Technological advancement in products, including PCR and next generation sequencing, along with increasing investment in R&D by biotechnology companies are some of the dominant trends in the personalized cell therapy market. For instance, Osiris Therapeutics invested around US$ 299 million on research and development in 2014.

Better research and product development infrastructure in developed economies

There is a high demand for early diagnosis and prevention of chronic diseases in both developed and emerging economies. The North America personalized cell therapy market dominated the global market in terms of revenue in 2016. The high prevalence of cancer and availability of advance healthcare infrastructure are some of the major factors contributing toward its large share. According to the World Cancer Research Fund, around one-third of the cancer cases occur in developed countries such as the U.S., owing to lack of physical activity, overweight or obesity, and unhealthy diet.

The key players operating in the global personalized cell therapy market include Osiris Therapeutics, Inc., RTI Surgical, Inc., JCR Pharmaceuticals Co., Ltd. MEDIPOST Co., Ltd., Pharmicell Co., Ltd., Anterogen Co., Ltd., NuVasive, Inc., Holostem Terapie Avanzate S.r.l., and AlloSource.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Key Benifits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.